Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases

Targeting of the PD1/PD-L1 immune checkpoint pathway has rapidly gained acceptance as a therapeutic strategy for a growing number of malignancies. Testing for expression of PD-L1 in tumor cells and immune cells has been used as a companion or complementary test for drugs targeting the PD1/PD-L1 path...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Malley, Dennis P., Yang, Yuhang, Boisot, Saskia, Sudarsanam, Sucha, Wang, Jian-Feng, Chizhevsky, Vladislav, Zhao, Guohua, Arain, Shehla, Weiss, Lawrence M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760643/
https://www.ncbi.nlm.nih.gov/pubmed/30760860
http://dx.doi.org/10.1038/s41379-019-0210-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760643/
https://www.ncbi.nlm.nih.gov/pubmed/30760860
http://dx.doi.org/10.1038/s41379-019-0210-3

Ejemplares similares